NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/13/2026
Back to search
Official data from USPTO
INTELLIA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
66
Latest update
01/14/2026
Classification
Registered
Trademark type
Combined
Nice classes
5, 42
Filing date
09/15/2014
Registration date
12/25/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/13/2026
Last transaction
01/14/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2017-01-00
First use in commerce
2017-01-00
Drawing code
3
Owner type
03
Owner location
Cambridge, MA
Examiner
ANDERSON, CASSONDRA CR
Current location
Historical data usage
Mark description
The mark consists of the word "INTELLIA" with the last two letter "Ls" in a broken bar pattern over the word "THERAPEUTICS".
Holders and representatives
Holders
Intellia Therapeutics, Inc.
Representatives
Jonathan M. Gelchinsky PIERCE ATWOOD LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and biological preparations based on genegenome and cellular editingmodulationmodificationengineeringregulationrepair and therapy for use in human therapeutics
Class 42
Scientific and medical researchbioinformatic algorithms and models in the fields of genegenome and cellular editingmodulationmodificationengineeringregulationrepair and therapy to develop human pharmaceutical and biological preparations and diagnostic products and services; scientific study and research in the fields of genegenome and cellular editingmodulationmodificationengineeringregulationrepair and therapy to develop human pharmaceutical and biological preparations and diagnostic products and services
Publications
History of USPTO decisions and trademark events.
66 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/13/2026
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/06/2025
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
04/07/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/07/2025
E815
TEAS SECTION 8 & 15 RECEIVED
12/23/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/25/2023
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
03/07/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/05/2019
ES7R
TEAS SECTION 7 REQUEST RECEIVED
01/18/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
12/25/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/22/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/21/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/30/2018
IUAF
USE AMENDMENT FILED
10/26/2018
EISU
TEAS STATEMENT OF USE RECEIVED
10/26/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/23/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/23/2018
DOCK
ASSIGNED TO EXAMINER
06/20/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/28/2018
EX5G
SOU EXTENSION 5 GRANTED
04/27/2018
EXT5
SOU EXTENSION 5 FILED
04/16/2018
EEXT
SOU TEAS EXTENSION RECEIVED
04/16/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/16/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/16/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/10/2017
EX4G
SOU EXTENSION 4 GRANTED
10/06/2017
EXT4
SOU EXTENSION 4 FILED
10/06/2017
EEXT
SOU TEAS EXTENSION RECEIVED
10/06/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/21/2017
EX3G
SOU EXTENSION 3 GRANTED
04/19/2017
EXT3
SOU EXTENSION 3 FILED
04/19/2017
EEXT
SOU TEAS EXTENSION RECEIVED
04/19/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/05/2016
EX2G
SOU EXTENSION 2 GRANTED
11/04/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/03/2016
EXT2
SOU EXTENSION 2 FILED
10/17/2016
EEXT
SOU TEAS EXTENSION RECEIVED
10/17/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/27/2016
EX1G
SOU EXTENSION 1 GRANTED
04/25/2016
EXT1
SOU EXTENSION 1 FILED
04/25/2016
EEXT
SOU TEAS EXTENSION RECEIVED
04/25/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/27/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/01/2015
PUBO
PUBLISHED FOR OPPOSITION
09/01/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/12/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/30/2015
ALIE
ASSIGNED TO LIE
07/30/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/20/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
06/08/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/08/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
06/08/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/08/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/08/2015
GNFR
FINAL REFUSAL E-MAILED
06/08/2015
CNFR
FINAL REFUSAL WRITTEN
06/08/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/22/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/21/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/21/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/01/2014
GNRT
NON-FINAL ACTION E-MAILED
12/01/2014
CNRT
NON-FINAL ACTION WRITTEN
12/01/2014
DOCK
ASSIGNED TO EXAMINER
11/25/2014
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/23/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/22/2014
NWAP
NEW APPLICATION ENTERED
09/18/2014
Continuous trademark protection
Get notified about every new filing that threatens INTELLIA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.